Skip to content

How to appeal a Wegovy or Zepbound insurance denial

By the glp1doses editorial team
Every number is checked against FDA labels and official price pages. How we check

The short answer

To appeal a Wegovy or Zepbound denial, get the denial reason and the plan's criteria in writing, then answer that exact reason with documents from your prescriber. In published insurer policies, the usual sticking points are baseline BMI, proof of a weight program, and step therapy (trying other medicines first). An excluded benefit can't be won on clinical grounds.

Key takeaways

  • Get the denial reason, the criteria used and the appeal deadline in writing first.
  • Answer the exact reason with dated records from your prescriber, such as baseline BMI or weight program notes.
  • If your plan excludes weight-loss drugs, a clinical appeal won't add the benefit. Ask your employer's benefits team instead.
  • Send the appeal the way your denial letter says, before its deadline, and keep a copy.
  • If the appeal is refused, ask for the reason again and for the next level of review.

A denial is a specific statement. Your plan is saying which rule your request didn’t meet. An appeal that answers that rule with evidence has a chance. An appeal that only says the medicine matters to you doesn’t address what the plan asked. This page shows you how to find the rule and answer it, using what insurers’ published policies say they look for.

This is general information, not legal advice. Your appeal rights and deadlines depend on your plan type and where you live, and your denial letter is the document that states yours.

Step 1: get the reason in writing

If you heard about the denial at the pharmacy counter or by phone, you don’t have what you need yet. Ask the plan for:

  • the written denial, with the reason;
  • the criteria or policy it applied;
  • the instructions and deadline for an appeal.

Then find the deadline and write it down. The number of days varies by plan.

Step 2: work out which kind of “no” it is

Refusals tend to fall into five kinds, and each has a different answer.

The benefit is excluded

Some plans don’t cover weight-loss medicines at all. Blue Cross Blue Shield of Massachusetts excludes Wegovy, Saxenda and Zepbound as plans renew on or after January 1, 2026. Blue Cross Blue Shield of Michigan doesn’t cover GLP-1 drugs used for weight loss for commercial members of fully insured large groups and some self-funded groups. UnitedHealthcare covers them only where the employer elected its optional program. Cigna’s policies say the plan document overrides the policy.

A clinical appeal doesn’t add a benefit. Here’s what can work:

  • Ask your employer’s benefits team whether the coverage can be added. In Massachusetts, employer groups with more than 100 employees have that option.
  • Ask your prescriber whether the drug is being prescribed for an approved use your plan does cover, and whether the request should be filed under that use.
  • Ask the plan whether it has an exception process, and get the answer in writing.

A criterion was not met

This is the kind you can most often answer. The plan says a requirement was missing, and you show that it’s met. These items come up again and again in published policies:

  • Baseline BMI. Aetna’s policy 6450-C requires documentation of a baseline BMI of 35 or more. “Baseline” means before treatment. If the request carried your current weight after months of treatment, the fix may be the earlier measurement.
  • Weight program history. Aetna asks for at least 6 months in a comprehensive weight management program, and Cigna for at least 3 months of behavioral modification and dietary restriction. Dated records answer this.
  • A qualifying condition. If you’re relying on a lower BMI threshold, the condition has to be documented.

If the plan had the documents and still said no, say so in the appeal and point to the page.

Step therapy was not satisfied

Step therapy means the plan wants another medicine tried first. Kaiser Permanente Northwest requires older weight-loss medicines and then at least 6 months of semaglutide before Zepbound. Highmark requires a documented intolerance or contraindication (a medical reason you can’t take it) to plan-preferred Zepbound before Wegovy.

There are two honest answers. One is the record: the medicines you tried, with dates and results. The other is a medical exception. FEP Blue’s Zepbound policy accepts “a valid medical exception (e.g., inadequate treatment response, intolerance, contraindication),” and Highmark’s bulletin describes a contraindication as a “documented allergic reaction, hypersensitivity.” Only your prescriber can say whether an exception applies to you, and it must be in your chart. An appeal should never ask you to take a medicine your prescriber considers unsuitable.

The form is not covered

Blue Cross Blue Shield of Michigan lists the Zepbound KwikPen as not covered, while the auto-injector is a preferred brand. UnitedHealthcare says Wegovy tablets are typically excluded. If the form was the problem, the quickest fix may be a talk with your prescriber about whether the covered form suits you. If there’s a medical reason for the form prescribed, that reason goes in a formulary exception request (a request to cover something that isn’t on the plan’s drug list).

A renewal was refused

Renewals in the policies we hold depend on documented weight loss from baseline and, at Aetna, time at a stable maintenance dose. Check which weight the plan used as your baseline and whether a current weight was on file. If a number was wrong, correct it with the chart record.

Step 3: build the appeal with your prescriber

Plans decide on clinical records, so your prescriber’s office is your partner. Ask them for:

  1. A letter of medical necessity that answers the stated denial reason point by point.
  2. The chart notes that prove each point, with dates.
  3. Whether resubmitting with the missing document is faster than a formal appeal.
  4. Whether the prescriber can speak with the plan’s reviewer, if the plan offers that.

The prior authorization checklist lists what insurers commonly ask for, so you can check that nothing else is missing while you’re at it.

Step 4: write and send it

Keep the letter short and factual: who you are, the drug, the approved use, what the plan said, and why the attached records answer the stated reason. Ask the plan to send the specific criteria and the next appeal step if it refuses again.

The appeal letter generator builds that letter in your browser. It takes the approved-use wording from the medicine’s FDA label, leaves anything you didn’t fill in as a bracketed blank, and stores nothing. It’s a starting template and doesn’t replace your prescriber’s documentation.

Send the appeal by the method your denial letter names, keep a copy, and note the date and any reference number.

Step 5: if the appeal is refused

Ask again for the reason and for the next level. Many plans have more than one level of internal review, and some denials can go to an independent outside reviewer. Your denial letter says which of these apply to you and how to request them. If your plan comes through an employer, your benefits team can also tell you who handles appeals.

While you wait

An appeal takes time, and treatment decisions in the meantime belong to you and your prescriber. If you choose to pay cash while the appeal runs, self-pay prices start at $149 a month for Wegovy and $299 for Zepbound, as the without-insurance guide explains. Keep in mind that manufacturer self-pay programs don’t use insurance, and their terms don’t let you seek reimbursement afterward. If you have commercial insurance that doesn’t cover the Zepbound single-dose pen, Lilly’s separate offer is $499 a month. The savings card page has the terms.

For rules at a specific insurer, start from the insurance guide, which links to each one’s page.

Frequently asked questions

How do I appeal a Wegovy denial?

Ask your plan for the denial reason and the criteria it used, in writing. Take both to your prescriber, and answer the specific reason with documents: baseline BMI, weight program records, or the history of medicines you've tried. Send the appeal the way the denial letter says and before the deadline it gives. Keep copies of everything.

Why was my Zepbound prior authorization denied?

Your denial letter gives the reason. In the published policies we hold, the common hurdles for Zepbound are a BMI threshold, proof of a weight program lasting 3 to 6 months, and step therapy. FEP Blue asks for two oral medicines and its preferred product first, and Kaiser Permanente Northwest asks for at least 6 months of semaglutide first.

Can I appeal if my plan excludes weight loss drugs?

You can ask your plan what its exception process is, but an exclusion is a decision about what the plan covers, not a judgment about you. Blue Cross Blue Shield of Massachusetts, for example, excludes Wegovy, Saxenda and Zepbound as plans renew from January 1, 2026. The more direct route is your employer, who chooses the benefit.

How long do I have to appeal an insurance denial?

Your plan and the rules that apply to it set the deadline, and your denial letter states it. It differs between plans. Find the date in the letter as soon as it arrives. If you can't find one, call the plan and ask for it in writing.

Does an appeal letter need to come from my doctor?

Either you or your prescriber can write to the plan. Plans usually want clinical information from the prescriber, so a letter from you is strongest when it comes with your prescriber's notes or a letter of medical necessity. Our appeal letter generator words the letter for whichever of you is signing.

Sources (11)

  1. 1.
    Blue Cross Blue Shield Federal Employee Program: 5.99.031 Zepbound
    “Zepbound may be considered medically necessary if the conditions indicated below are met. ... the patient has a valid medical exception (e.g., inadequate treatment response, intolerance, contraindication)”
  2. 2.
    Highmark Pharmacy Policy Bulletin: J-1388 Anti-Obesity (Enhanced), Commercial and Healthcare Reform (Version J-1388-028, dated 2026-07-01)
    “When a benefit, initiation of Saxenda (liraglutide), Foundayo, Wegovy, or Zepbound may be approved when all of the following criteria are met (1. through 8.): ... contraindication (specifically, documented allergic reaction, hypersensitivity) to plan-preferred Zepbound.”
  3. 3.
    UnitedHealthcare: Prior Authorization/Notification, Weight Loss/Appetite Suppression Medication Coverage (Program Number 2026 P 1114-23, dated 2026-10-01)
    “This is an optional program that is put in place for clients or businesses that have elected to cover weight loss products with Prior Authorization/Notification. ... * Wegovy tablets are typically excluded from coverage.”
  4. 4.
    Blue Cross Blue Shield of Massachusetts: GLP-1 Coverage: Frequently Asked Questions
    “On anniversary, starting January 1, 2026, Wegovy, Saxenda, and Zepbound will be excluded from coverage. ... Employer groups with more than 100 employees have the option of adding coverage for weight-loss drugs for an additional cost.”
  5. 5.
    Aetna: Weight Loss (BMI 35) GIP-GLP-1, GLP-1 Agonists PA with Limit 6450-C P08-2025 v8
    “Authorization may be granted when the requested drug will be used with a reduced-calorie diet AND increased physical activity to reduce excess body weight or maintain weight reduction long term when ALL of the following criteria are met: ... The patient has participated in a comprehensive weight management program that encourages behavioral modification, reduced-calorie diet, AND increased physical activity with continuing follow-up for at least 6 months prior to using drug therapy.”
  6. 6.
    Cigna Healthcare: Weight Loss, Glucagon-Like Peptide-1 Agonists, Zepbound (Coverage Policy Number IP0816, dated 2026-09-01)
    “Prior Authorization is required for benefit coverage of Zepbound. ... Patient has engaged in a trial of behavioral modification and dietary restriction for at least 3 months; AND”
  7. 7.
    Kaiser Permanente Northwest Region Criteria for Coverage: tirzepatide (Zepbound)
    “Zepbound is covered under the prescription drug benefit for weight loss ONLY for Kaiser Northwest members with coverage for medications used to treat weight loss. Others pay member cash price. ... Patient has then failed a minimum 6-month trial of semaglutide (Ozempic/Wegovy)”
  8. 8.
    Your 2026 Blue Cross Blue Shield of Michigan and Blue Care Network Preferred Drug List
    “We also don’t cover glucagon-like peptide-agonist drugs used for weight loss, including Saxenda®, Wegovy®, and Zepbound® for commercial members of fully insured large groups and some self-funded groups. ... ZEPBOUND KWIKPEN Not covered QL ZEPBOUND SUBCUTANEOUS SOLUTION AUTO-INJECTOR Preferred brand PA; QL”
  9. 9.
  10. 10.
  11. 11.